KLAC$1,829.47

KLA shows strong multi-year growth, with revenue rising from $6.9B in FY2021 to $12.2B in FY2025 and TTM revenue accelerating further to $13.1B. Net income has been more volatile, dipping in FY2024 but rebounding sharply in FY2025 and TTM, suggesting healthy underlying demand but some cyclical sensitivity. Margins remain excellent by semiconductor-equipment standards: gross margin stays near 60% and operating margin has largely recovered to about 40% TTM, indicating strong pricing power and operating leverage. Earnings look durable overall, with only modest volatility in other income and tax rates. Key risks are cyclical end-market exposure and occasional expense pressure, but the business remains high quality.

KLA’s balance sheet shows solid liquidity and improving equity support. Total current assets rose from $5.7 billion in FY2021 to $10.7 billion in FY2025, versus current liabilities of $4.1 billion, leaving a comfortable working-capital cushion. Cash and short-term investments remain strong at $4.5 billion, and TTM current assets of $11.4 billion exceed current liabilities of $3.8 billion. Solvency is reasonable: total liabilities of $11.4 billion are below total assets of $16.1 billion, while shareholders’ equity increased to $4.7 billion from $3.4 billion in FY2024. Debt is meaningful at $5.9 billion, but net debt has improved materially. The main caution is elevated inventory and still-significant intangible assets, though tangible book value has turned strongly positive.

Cash generation is strong and broadly improving. Operating cash flow rose from 2,185 million in FY2021 to 4,082 million in FY2025, with TTM at 4,402 million versus 4,082 million in the latest year, showing continued momentum. Free cash flow is also robust, increasing from 1,953 million to 3,747 million, and TTM FCF of 4,015 million implies healthy conversion after capital expenditures of 335 million. Working capital swings are noticeable, especially inventories and receivables, but they have not prevented solid cash production. Capital allocation is shareholder-friendly, with consistent dividends and large buybacks, though repurchases are heavy. Overall, cash quality is good, with only moderate volatility and no structural red flags.

KLA shows a generally strong non-financial profile. Liquidity has improved steadily, with the current ratio rising from 2.71 to 3.03 and the quick ratio from 1.81 to 1.94, indicating comfortable short-term coverage. Leverage is manageable and has trended down overall: debt-to-equity fell from 4.76 in FY2022 to 1.01 currently, while net debt metrics also improved, suggesting a healthier balance sheet. Efficiency is mixed, with asset turnover stable around 0.7-0.8 but inventory turnover weaker than earlier years, implying some softness in working-capital efficiency. Profitability remains excellent, with ROE, ROA, ROIC, and ROCE all strong despite some volatility, showing durable earnings power and effective capital use.

Historical data runs through FY2025, while FY2026 and FY2027 are analyst-covered forecast years. Revenue shows a clear cycle: strong expansion in FY2021-FY2023, a FY2024 contraction, then a solid recovery and renewed acceleration in the forecast period. EPS is more volatile than revenue, with the FY2024 decline followed by a strong rebound; projected EPS growth in FY2026-FY2027 outpaces revenue growth, suggesting improving margins or operating leverage. Forward P/E is high at 47.83 for FY2026 and moderates to 35.29 in FY2027, which is more defensible alongside the strong earnings growth, though still elevated. Sentiment is constructive: consensus is Buy, targets cluster tightly around the mid-to-upper 1800s, and 30 analysts support the view. Recommendation trends are broadly stable, with Hold roughly flat and no bearish ratings.